BOSTON ONCOLOGY ARABIA — Syringe Importer Profile
Pharmaceutical Importer · #3 buyer for Syringe · $4.5M import value · 95 shipments · SAUDI ARABIA · DGFT Verified
BOSTON ONCOLOGY ARABIA is the #3 importer of Syringe from India with $4.5M in import value and 95 verified shipments. BOSTON ONCOLOGY ARABIA holds a 2.6% market share in Syringe imports based in SAUDI ARABIA. The company sources from 1 verified supplier across 26 formulations shipped to 1 country. Overall, BOSTON ONCOLOGY ARABIA imports 5 pharmaceutical products worth $29.2M across 4 therapeutic categories.
BOSTON ONCOLOGY ARABIA — Syringe Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Syringe to BOSTON ONCOLOGY ARABIA?
Verified from 95 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $4.5M | 95 | 100.0% |
BOSTON ONCOLOGY ARABIA sources Syringe from 1 verified Indian supplier based on 95 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does BOSTON ONCOLOGY ARABIA Compare to Nearest Syringe Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLC | UNITED STATES | $17.1M | 341 | $50.0K |
| 2 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $4.8M | 95 | $50.0K |
| 3 | BOSTON ONCOLOGY ARABIA ★ | SAUDI ARABIA | $4.8M | 95 | $50.0K |
| 4 | FRESENIUS KABI USA LLC | UNITED STATES | $3.5M | 70 | $50.0K |
| 7 | EVERSANA | UNITED STATES | $3.5M | 70 | $50.0K |
BOSTON ONCOLOGY ARABIA ranks #3 among 751 Syringe importers from India. Average shipment value of $50.0K compared to the market average of $57.6K. The closest competitors by value are FRESENIUS KABI USA, LLC and YUSEN LOGISTICS BENELUX BELGIUM.
Where Does BOSTON ONCOLOGY ARABIA Import Syringe To?
Destination countries from 95 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $4.5M | 95 | 100.0% |
BOSTON ONCOLOGY ARABIA imports Syringe to 1 country. The primary destination is SAUDI ARABIA receiving 100.0% of shipments worth $4.5M.
What Syringe Formulations Does BOSTON ONCOLOGY ARABIA Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.2M | 24 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE | $691.9K | 14 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,80MG IN 0.8ML PRE-FILLED SYRINGE | $450.0K | 9 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGENOS | $450.0K | 9 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 80MG IN 0.8ML PRE-FILLED SYRINGE | $300.0K | 6 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0.6ML PRE-FILLED SYRINGE | $216.6K | 5 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 20MG IN 0.2ML PREFILLED SYRINGE | $187.2K | 4 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,60MG IN 0.6ML PRE-FILLED SYRINGE | $133.7K | 3 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP80MG IN 0.8ML PRE-FILLED SYRINGE | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0 6ML PRE FILLED SYRINGE | $50.0K | 1 |
BOSTON ONCOLOGY ARABIA imports 26 distinct Syringe formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP with 24 shipments worth $1.2M.
Who Are the Top Buyers of Syringe from India and How Much Does BOSTON ONCOLOGY ARABIA Import?
India exported $43.3M worth of Syringe through 3,522 shipments from 291 suppliers to 154 countries, serving 751 buyers globally. BOSTON ONCOLOGY ARABIA imports $4.5M of this total, accounting for 2.6% of India's Syringe exports with 95 shipments from SAUDI ARABIA. This is verified from 95 customs shipment records covering 26 distinct formulations.
What Is the Average Order Value for BOSTON ONCOLOGY ARABIA's Syringe Imports?
BOSTON ONCOLOGY ARABIA's average Syringe order value is $47.5K per consignment, based on 95 shipments totaling $4.5M. BOSTON ONCOLOGY ARABIA is based in SAUDI ARABIA and ranks #3 among all Syringe importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Syringe to BOSTON ONCOLOGY ARABIA?
BOSTON ONCOLOGY ARABIA sources Syringe from 1 verified Indian supplier: GLAND PHARMA LIMITED ($4.5M, 100.0%). This is based on 95 customs records.
How Does BOSTON ONCOLOGY ARABIA Compare to Other Syringe Importers?
BOSTON ONCOLOGY ARABIA ranks #3 among 751 Syringe importers from India with a 2.6% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($17.1M), YUSEN LOGISTICS BENELUX BELGIUM ($4.8M), BOSTON ONCOLOGY ARABIA ($4.8M). BOSTON ONCOLOGY ARABIA processed 95 shipments from SAUDI ARABIA.
About BOSTON ONCOLOGY ARABIA
BOSTON ONCOLOGY ARABIA imports 5 products worth $29.2M. Beyond Syringe, top products include Enoxaparin, Heparin, Everolimus, Dasatinib. View the complete BOSTON ONCOLOGY ARABIA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Syringe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BOSTON ONCOLOGY ARABIA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BOSTON ONCOLOGY ARABIA's capped import value divided by total capped export value for Syringe across all Indian exporters.
- 5.Verified Records: This page is backed by 95 individual customs records matching BOSTON ONCOLOGY ARABIA importing Syringe, covering 26 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 751+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Syringe Import Data for BOSTON ONCOLOGY ARABIA
Access order-level details, pricing data, supplier connections, and competitive analysis for BOSTON ONCOLOGY ARABIA's Syringe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BOSTON ONCOLOGY ARABIA
Full Company Profile →
5 products · $29.2M total trade · 4 categories
BOSTON ONCOLOGY ARABIA × Syringe
Verified from customs records
Company Overview
Top Products by BOSTON ONCOLOGY ARABIA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BOSTON ONCOLOGY ARABIA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Syringe. For current order-level data, contact TransData Nexus.